Your browser doesn't support javascript.
loading
Relationship Between Pain Alleviation and Disease-specific Health-related Quality of Life Measures in Patients With Chronic Low Back Pain Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study.
Enomoto, Hiroyuki; Sasaki, Nao; Fujikoshi, Shinji; Yoshikawa, Aki; Tsuji, Toshinaga; Takeshita, Katsushi.
Affiliation
  • Enomoto H; Medicines Development Unit Japan, Eli Lilly Japan K.K., Akasaka, Minato-Ku, Tokyo, Japan (Dr. Enomoto); the Medicines Development Unit Japan, Eli Lilly Japan K.K., Chuo-Ku, Kobe, Japan (Ms. Sasaki, Mr. Fujikoshi, and Ms. Yoshikawa); the Medical Affairs Department, Shionogi & Co., Ltd., Kita-ku,
  • Sasaki N; Medicines Development Unit Japan, Eli Lilly Japan K.K., Akasaka, Minato-Ku, Tokyo, Japan (Dr. Enomoto); the Medicines Development Unit Japan, Eli Lilly Japan K.K., Chuo-Ku, Kobe, Japan (Ms. Sasaki, Mr. Fujikoshi, and Ms. Yoshikawa); the Medical Affairs Department, Shionogi & Co., Ltd., Kita-ku,
  • Fujikoshi S; Medicines Development Unit Japan, Eli Lilly Japan K.K., Akasaka, Minato-Ku, Tokyo, Japan (Dr. Enomoto); the Medicines Development Unit Japan, Eli Lilly Japan K.K., Chuo-Ku, Kobe, Japan (Ms. Sasaki, Mr. Fujikoshi, and Ms. Yoshikawa); the Medical Affairs Department, Shionogi & Co., Ltd., Kita-ku,
  • Yoshikawa A; Medicines Development Unit Japan, Eli Lilly Japan K.K., Akasaka, Minato-Ku, Tokyo, Japan (Dr. Enomoto); the Medicines Development Unit Japan, Eli Lilly Japan K.K., Chuo-Ku, Kobe, Japan (Ms. Sasaki, Mr. Fujikoshi, and Ms. Yoshikawa); the Medical Affairs Department, Shionogi & Co., Ltd., Kita-ku,
  • Tsuji T; Medicines Development Unit Japan, Eli Lilly Japan K.K., Akasaka, Minato-Ku, Tokyo, Japan (Dr. Enomoto); the Medicines Development Unit Japan, Eli Lilly Japan K.K., Chuo-Ku, Kobe, Japan (Ms. Sasaki, Mr. Fujikoshi, and Ms. Yoshikawa); the Medical Affairs Department, Shionogi & Co., Ltd., Kita-ku,
  • Takeshita K; Medicines Development Unit Japan, Eli Lilly Japan K.K., Akasaka, Minato-Ku, Tokyo, Japan (Dr. Enomoto); the Medicines Development Unit Japan, Eli Lilly Japan K.K., Chuo-Ku, Kobe, Japan (Ms. Sasaki, Mr. Fujikoshi, and Ms. Yoshikawa); the Medical Affairs Department, Shionogi & Co., Ltd., Kita-ku,
J Am Acad Orthop Surg Glob Res Rev ; 3(11)2019 Nov.
Article in En | MEDLINE | ID: mdl-31875196
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Language: En Journal: J Am Acad Orthop Surg Glob Res Rev Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Language: En Journal: J Am Acad Orthop Surg Glob Res Rev Year: 2019 Document type: Article